J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,810.00
-160.00 (-2.01%)
At close: Jun 5, 2026

J2KBIO Revenue

J2KBIO had revenue of 11.13B KRW in the quarter ending March 31, 2026, with 53.08% growth. This brings the company's revenue in the last twelve months to 36.82B, up 13.00% year-over-year. In the year 2025, J2KBIO had annual revenue of 32.97B, down -0.49%.

Revenue (ttm)
36.82B
Revenue Growth
+13.00%
P/S Ratio
1.24
Revenue / Employee
681.93M
Employees
54
Market Cap
45.67B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202532.97B-162.83M-0.49%
Dec 31, 202433.13B4.66B16.36%
Dec 31, 202328.47B12.44B77.60%
Dec 31, 202216.03B1.81B12.75%
Dec 31, 202114.22B360.95M2.60%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Psomagen60.70B
ADBiotech12.51B
Eutilex.Co.,Ltd9.51B
HLB Pep5.52B
Quratis1.26B
Kainos Medicine1.17B
Aptamer Sciences1.08B
Progen450.00M
Revenue Rankings